共 50 条
- [45] Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer? [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 422 - 428
- [47] EGFR Mutation in Non-Small Cell Lung Cancer is Influenced by EGFR Amplification and Biomarkers [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 655 - 655
- [48] Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC) [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (12): : 2607 - 2614